Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Sung Won Choi, Tracey Churay et al.|Bone Marrow Transplantation|2019Cited by 22
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic TransplantationJohn Magenau, Sung Won Choi, Thomas Braun et al.|Transplantation and Cellular Therapy|2019Cited by 6